# US 2013/0296411 A1 · Use of Artemisinin for Treating Tumors Induced by oncogenic Viruses and for Treating Viral Infections

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0296411 A1
- Document ID: US20130296411A1
- Status: Published application
- Kind: A1
- Application number: 13/777,244
- Filed: 2013-02-26
- Published: 2013-11-07
- Earliest claimed: 2003-02-12
- Assignees: Georgetown University
- Applicants: Georgetown University
- Inventors: Richard SCHLEGEL; Dan-Paul HARTMANN; Astrid BAEGE
- Web page: https://patentgrep.com/patent/US20130296411A1

## CPC

- A61K 31/366: having six-membered rings, e.g. delta-lactones
- A61K 31/335: having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K 31/357: having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K 31/365: Lactones
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 31/12: Antivirals
- A61P 31/14: for RNA viruses
- A61P 31/20: for DNA viruses
- A61P 35/00: Antineoplastic agents
- C07D 493/18: Bridged systems
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

In certain aspects, the invention relates to methods of treating proliferative cervical disorders (such as cervical cancer and cervical dysplasia) and treating virus infection by administering artemisinin-related compounds. In certain aspects, the invention relates to methods of treating a tumor induced by an oncogenic virus, methods of killing or inhibiting a squamous cell carcinoma, and methods of inhibiting the replication of a virus, by administering artemisinin-related compounds.

## Claims

### Claim at position 1

1-54. (canceled)

### Claim 55

A method of treating Human papillomavirus (HPV)-induced anal cancer in a human subject, the method comprising:
identifying a subject with HPV-induced anal cancer, and
administering a therapeutically effective amount of an artemisinin-related compound to the identified subject, wherein the artemisinin-related compound is artemisinin, dihydroartemisinin, artemether, arteether, artesunate, artelinic acid, dihydroartemisinin propyl carbonate, or any combination thereof, and
wherein the artemisinin-related compound is administered to the identified human subject by oral administration, topical administration, parenteral administration, rectal administration, systemic administration, intramuscular administration, or intravenous administration.

### Claim 56 (depends on 63)

The method of claim 63, wherein the artemisinin-related compound is artemisinin.

### Claim 57 (depends on 63)

The method of claim 63, wherein the artemisinin-related compound is artesunate.

### Claim 58 (depends on 63)

The method of claim 63, wherein the artemisinin-related compound is formulated with a pharmaceutically acceptable carrier.

### Claim 59 (depends on 63)

The method of claim 63, wherein the artemisinin-related compound is administered with an anti-viral agent.

### Claim 60 (depends on 67)

The method of claim 67, wherein the artemisinin-related compound and the anti-viral agent are in the same formulation.

### Claim 61 (depends on 63)

The method of claim 63, wherein the artemisinin-related compound is administered with an anti-cancer agent.

### Claim 62 (depends on 69)

The method of claim 69, wherein the artemisinin-related compound and the anti-cancer agent are in the same formulation.
